Düsseldorf, Germany – November 20, 2025 – Sonostar, the world’s first manufacturer of AI-integrated ultrasound probes, has successfully participated in MEDICA 2025, the world’s leading medical technology exhibition held at Messe Düsseldorf from November 17 to 20. Aligned with this year’s MEDICA theme “Meet Health. Future. People.”, Sonostar’s cutting-edge ultrasound solutions have drawn extensive attention from healthcare professionals, distributors, and hospital procurement teams across over 70 countries, solidifying its presence in the European and global medical markets.

As the most influential event in the global healthcare industry, MEDICA 2025 gathered over 5,000 exhibitors and 80,000+ professional attendees, focusing on transformative trends such as AI in medical imaging, integrated care, and telemedicine . Sonostar’s booth became a key attraction, showcasing its flagship AI-integrated ultrasound probes covering multiple clinical areas including MSK, urology, and thyroid detection. Live demonstrations highlighted the probes’ real-time high-resolution imaging capabilities and AI-assisted pathological identification functions, which significantly optimize diagnostic workflows and improve accuracy.

“MEDICA provides an unparalleled platform for us to connect with global healthcare leaders and demonstrate how our AI-powered ultrasound technologies align with the evolving needs of precision medicine,” said a Sonostar representative at the exhibition. “Our focus on high intelligence, reliability, and compliance with international standards like EU MDR has resonated strongly with attendees, especially those from European healthcare systems.”

A key highlight of Sonostar’s participation was the in-depth discussions on clinical applications and international collaborations. Many attendees expressed strong interest in the company’s solutions, with several preliminary cooperation intentions signed with distributors from Germany, France, and the Middle East. This not only strengthens Sonostar’s market penetration in Europe but also lays a solid foundation for expanding its global supply chain .

Beyond showcasing innovations, Sonostar actively engaged in MEDICA’s professional forums, sharing insights on AI integration in ultrasound technology and exchanging ideas with industry peers on regulatory compliance and global healthcare collaboration. The company’s successful participation in MEDICA 2025 reaffirms its commitment to driving technological innovation in the global medical imaging industry and providing high-quality healthcare solutions to patients worldwide.

For more information on Sonostar’s innovations and MEDICA highlights, please visit the company’s official website.

### About Sonostar Sonostar is dedicated to developing high-quality, high-tech, and highly intelligent medical imaging solutions. As the pioneer of AI-integrated ultrasound probes, the company strives to empower healthcare providers with advanced technologies to enhance diagnostic efficiency and improve patient outcomes. With its European Sales Headquarters, Sonostar continues to expand its international footprint and promote global healthcare collaboration.